SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
CORRESP | CORRESP |
View HTML | |
CORRESP | CORRESP |
View HTML | |
CORRESP | CORRESP |
View HTML | |
CORRESP | CORRESP |
View HTML | |
CORRESP | CORRESP |
View HTML | |
CORRESP | CORRESP |
View HTML | |
CORRESP | CORRESP |
View HTML | |
CERTNAS | CERTNAS |
View HTML | |
10-K | Annual report which provides a comprehensive overview of the company for the past year |
View HTML EX-101.INS - EX-101.INS | |
10-K | Annual report which provides a comprehensive overview of the company for the past year |
View HTML EX-101.INS - EX-101.INS |
Displaying 821 - 830 of 958 results
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.